Toronto Thromboprophylaxis Patient Safety Initiative (TOPPS)
Toronto Thromboprophylaxis Patient Safety Initiative (TOPPS): A Cluster Randomized Trial
Sponsor: Lakeridge Health Corporation
This NA trial investigates Venous Thromboembolism and is currently completed. Lakeridge Health Corporation leads this study, which shows 9 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Oct 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
-
Oct 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Oct 2019 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lakeridge Health Corporation
- Markham Stouffville Hospital
- Michael Garron Hospital
- North York General Hospital
- Scarborough General Hospital
- Sunnybrook Health Sciences Centre
- Trillium Health Centre
- York Central Hospital, Ontario
For direct contact, visit the study record on ClinicalTrials.gov .